The World Health Organisation Global Influenza Programme 2024 / 2025 (WHO) recommended that quadrivalent vaccines for use in the 2024 - 2025 season contain the following strains of the flu virus, as they predict that these strains will be the most prevalent across the northern hemisphere this flu season:
Egg-based vaccines
- A/Victoria/4897/2022 (H1N1)pdm09-like virus
- A/Thailand/8/2022 (H3N2)-like virus
- B/Austria/1359417/2021 (B/Victoria lineage)-like virus
- B/Phuket/3073/2013 (B/Yamagata lineage)-like virus
Cell culture- or recombinant-based vaccines
- A/Wisconsin/67/2022 (H1N1)pdm09-like virus
- A/Massachusetts/18/2022 (H3N2)-like virus
- B/Austria/1359417/2021 (B/Victoria lineage)-like virus
- B/Phuket/3073/2013 (B/Yamagata lineage)-like virus